A
Aditxt, Inc. (ADTX)
NCM – Real vaqt narxi. Valyuta: USD
0.09
-0.02 (-22.16%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.08
-0.01 (-5.88%)
Bozor oldidan: May 13, 2026, 6:16 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.09
-0.02 (-22.16%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.08
-0.01 (-5.88%)
Bozor oldidan: May 13, 2026, 6:16 AM EDT
Aditxt, Inc. biofarmatsevtika mahsulotlarini kashf qilish va ishlab chiqishga qaratilgan. Kompaniya odamlarga immunitet profillarini tushunish, boshqarish va kuzatish imkonini beruvchi AditxtScore va FlowSpotni ishlab chiqadi, bu esa ularga immunitet tizimiga yoki immunitet tizimidan hujumlar haqida xabardor bo'lish imkonini beradi; va Apoptotic DNA Immunotherapy - bu tana to'qimalariga tabiiy ravishda tolerantlikni qanday keltirib chiqarish usulini taqlid qiluvchi nuklein kislota asosidagi texnologiya. U teri ko'chirib o'tkazish, psoriaz va 1-toifa diabet uchun ADI-100ni ishlab chiqadi. Bundan tashqari, kompaniya saratonni erta aniqlash uchun testlarni ishlab chiqish uchun mitoxondrial DNK (mtDNA) asosida molekulyar testlarni ishlab chiqadigan Pearsanta; kasallikni aniqlash uchun mitoxondrial DNK (mtDNA) dagi mutatsiyalarga qaratilgan Mitomic; 3,4kb mtDNA o'chirilish darajasini miqdorini aniqlaydigan qon asosidagi tahlil bo'lgan Mitomic prostata testi; va bir yoki bir nechta mtDNA o'chirilish darajasini miqdorini aniqlaydigan qon asosidagi tahlil bo'lgan Mitomic endometrioz testi taqdim etadi. Bundan tashqari, u yuqumli kasalliklar va aholi salomatligidagi muhim ehtiyojlarni qondirish uchun mahsulotlarni tijoriy rivojlantirish uchun Adivir; va ayollar salomatligidagi muhim ehtiyojlarni qondirish uchun Adifemni taklif etadi. Kompaniya Loma Linda universiteti va Leland Stanford Junior universiteti bilan litsenziya shartnomasiga ega. Kompaniya ilgari ADiTx Therapeutics, Inc. nomi bilan tanilgan va 2021 yil iyul oyida Aditxt, Inc. nomini o'zgartirgan. Aditxt, Inc. 2017 yilda ro'yxatga olingan va shtab-kvartirasi Mountain View, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Dolly B. Tyan D(ABHI), Ph.D. | Senior Vice President of Clinical Development Transplantation |
| Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D. | Co-Founder, Chief Innovation Officer, Secretary & Director |
| Mr. Amro A. Albanna | Co-Founder, Chairman & CEO |
| Mr. Christopher J. Porcelli | General Counsel & Chief People Officer |
| Mr. Ge Chen M.D., M.S. | Senior Vice President of Preclinical Research & Discovery |
| Mr. Thomas J. Farley CPA |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 8-K | ea0289662-8k_aditxt.htm |
| 2026-05-01 | 8-K | ea0288779-8k_aditxt.htm |
| 2026-04-14 | 8-K | ea0286168-8k_aditxt.htm |
| 2026-04-13 | S-3 | ea0285732-s3_aditxt.htm |
| 2026-04-07 | 8-K/A | ea0285319-8ka1_aditxt.htm |
| 2026-04-02 | 8-K | ea0284653-8k_aditxt.htm |
| 2026-03-31 | 10-K | ea0283141-10k_aditxt.htm |
| 2026-03-30 | 8-K | ea0283979-8k_aditxt.htm |
| 2026-03-24 | PRE 14A | ea0283212-pre14a_aditxt.htm |
| 2026-03-13 | 8-K | ea0279443-8k_aditxt.htm |
| Chief Financial Officer |
| Ms. Corinne D. Pankovcin CPA, M.B.A. | Chief Mergers & Acquisitions Officer |
| Ms. Jennifer Lee | Director of Human Resources |
| Ms. Rowena Albanna | Chief Operating Officer |